大型南亚队列的泪液非靶向蛋白质组学揭示圆锥角膜中的炎症信号、细胞外基质重塑和代谢改变
研究对69名圆锥角膜患者的107只不同分级患眼和40名健康对照者的泪液进行iTRAQ定量蛋白质组学分析,鉴定出1104种蛋白,其中279种定量,32种在患者泪液中显著失调,富集于糖酵解、细胞外基质组织、活性氧解毒和炎症调节通路;胱抑素S、泪液蛋白、谷胱甘肽合成酶和超氧化物歧化酶在各圆锥角膜分级中验证出差异表达。
要点
- 泪液蛋白质组学发现32种蛋白在圆锥角膜中显著失调,涉及糖酵解、细胞外基质组织和炎症调节等通路。
- 胱抑素S、泪液蛋白、谷胱甘肽合成酶和超氧化物歧化酶在各圆锥角膜分级中差异表达。
- 新鉴定的分子通路可能作为圆锥角膜的治疗靶点。
核心结论
- 泪液蛋白质组学揭示了圆锥角膜中参与中性粒细胞脱颗粒、自噬、代谢改变和蛋白磷酸化等独特生物学过程的新蛋白,以及细胞外基质调节和炎症通路。
- 新鉴定的进展性圆锥角膜生物标志物有助于疾病表征,所鉴定的分子通路可能作为新的治疗靶点。
研究设计与样本
- 队列包括40名健康个体和来自69名个体的107只不同圆锥角膜分级的患眼。
- 采用iTRAQ标记结合二维纳升液相色谱-电喷雾串联质谱(TripleTOF 5600)进行定量蛋白质组学分析,随后进行验证。
主要发现
- 非靶向液相色谱-串联质谱分析鉴定出1104种蛋白,其中279种被定量。
- 与对照相比,32种蛋白在泪液中表现出显著失调,富集于糖酵解通路、细胞外基质组织、活性氧解毒和炎症调节。
- 胱抑素S、泪液蛋白、谷胱甘肽合成酶和超氧化物歧化酶被验证在各圆锥角膜分级中具有差异表达。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Keratoconus (KC), a progressive corneal degenerative disease, is characterized by focal thinning and weakening, and the molecular pathways driving such changes are still being discovered. The progression-related pathologic molecular factors have not been identified in genetic studies from KC, and stage-specific molecular changes remain unknown in prior protein studies. We address this challenge through untargeted mass spectrometry analysis in a large KC cohort. METHODS: The cohort comprised 40 healthy individuals and 107 eyes with varying KC grades from 69 individuals. Quantitative proteomics using iTRAQ labeling coupled with two-dimensional nanoLC-ESI-MS/MS (TripleTOF 5600) was employed followed by validation. RESULTS: Unbiased LC-MS/MS analysis identified 1104 proteins, with 279 quantified proteins. Thirty-two proteins exhibited significant dysregulation in tear fluids compared to the control, enriched in glycolytic pathways, extra-cellular matrix (ECM) organization, reactive oxygen detoxification, and inflammatory regulation. Cystatin-S, lacritin, glutathione synthetase, and superoxide dismutase were validated to have differential expression across each KC grade. CONCLUSIONS: Our data unveiled novel tear fluid proteins involved in unique biological processes such as neutrophil degranulation, autophagy, metabolic alterations, protein phosphorylation, and more, apart from the ECM modulation and inflammatory pathways. Although the newly identified progressive KC biomarkers will help in disease characterization, identified molecular pathways may serve as novel therapeutic targets.
引用
- Kannan R, Shetty R, Panigrahi T, et al. Untargeted Tear Proteomics in a Large South-Asian Cohort Reveals Inflammatory Signaling, ECM Remodeling, and Altered Metabolism in Keratoconus. Invest Ophthalmol Vis Sci. 2025. PMID: 39992672. doi:10.1167/iovs.66.2.60
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。